R1 has acquired Humata, the healthcare technology company founded by radiologist Jeremy Friese. Transaction counsel Dentons confirmed in September that the deal had closed, following R1's agreement to acquire the company in August 2026. Financial terms were undisclosed.
Humata traces its beginnings to Friese's work as a radiologist, where he saw care delayed while his team dealt with piles of faxes. A small group began tackling that problem about a decade ago, and its technology eventually reached major health systems.
According to the source, the buyer gives Humata a wider setting for its work. R1 manages healthcare revenue, and its Phare OS platform covers authorisation, utilisation review, documentation and coding before a bill goes out. Humata adds technology connecting providers' requests with payer decisions.
The source describes commercial significance in that sequence: an authorisation problem can delay an appointment long before it becomes a rejected claim, and linking the approval process to later billing work gives the combined business a chance to identify missing information earlier and carry the same clinical evidence through subsequent steps.
R1 also plans to bring Humata's team into its R37 development group, so the integration involves people who understand the exceptions in a difficult workflow alongside the software.
The source frames the deal as R1 paying to reach an earlier point in the hospital's cash collection process, making the handoff between authorisation and billing central to its value. It notes that if staff still have to rebuild a case after approval, much of the opportunity remains unclaimed, and that reducing that repeated work is what would make the combination useful to customers.